EPISODE · Sep 21, 2017 · 8 MIN
Can We Simplify the Treatment of Myelofibrosis?
from Journal of Clinical Oncology (JCO) Podcast · host Vikas Gupta
In this randomized trial, momelotinib was non-inferior to ruxolitinib for spleen response but was less effective in controlling symptoms. Related Article: SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis
Embed this episode
NOW PLAYING
Can We Simplify the Treatment of Myelofibrosis?
0:00
8:51
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Journal of Clinical Oncology (JCO) Podcast?
This episode is 8 minutes long.
When was this Journal of Clinical Oncology (JCO) Podcast episode published?
This episode was published on September 21, 2017.
Can I download this Journal of Clinical Oncology (JCO) Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!